Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study
Xiang Lin, Guixia Wang, Yulei Zhuang, Lin Luo, Jiangyu Yan, Hong Zhang, Xiaojiao Li, Can Xie, Qingwei He, Yu‐Yu Peng, Hong Chen, Qianqian Li, Xiaoping Li, Linfeng Guo, Guoyue Lv, Yanhua Ding
Topics & Concepts
Double blindPlaceboMedicineAgonistRandomized controlled trialDual (grammatical number)Placebo-controlled studyInternal medicineReceptorAlternative medicinePhilosophyLinguisticsPathologyFibroblast Growth Factor ResearchLiver Disease Diagnosis and TreatmentDiabetes Treatment and Management